While browsing Pendle recently, I came across 3Jane's USD3 market.

The headline numbers were hard to ignore.

Some estimates suggested APYs above 100%, while others claimed that $1,000 invested in YT-USD3 could provide exposure to more than $20,000 worth of yield.

At first glance, it looked extremely attractive.

After digging deeper, however, I decided to pass.

Not because 3Jane is a bad project, but because the opportunity wasn't what it initially appeared to be.

3Jane is a Paradigm-backed credit protocol focused on bringing credit markets on-chain.

Unlike Aave or Morpho, which rely on overcollateralized lending, 3Jane aims to build a credit-based system where yield is generated from real-world credit activities.

Its flagship product, USD3, is a yield-bearing stablecoin designed to give users exposure to private credit opportunities.

From a narrative perspective, it's hard to find a stronger combination:

• Private Credit

• RWA

• Yield-Bearing Stablecoins

• On-Chain Credit Markets

These are some of the most compelling themes in DeFi today.

The more I looked into the numbers, the more one thing became clear:

The triple-digit APY is not primarily coming from USD3 itself.

The return is a combination of:

• Base USD3 yield

• Pendle incentives

• JANE token emissions

And the largest contributor is often JANE.

In other words, investors are not simply buying yield.

They are making a bet on the future value of the JANE token.

What caught my attention was how many yield calculations relied on a projected JANE FDV of $250 million.

The issue is simple:

Why $250 million?

What's the underlying justification?

Without a valuation framework, the APY estimate becomes highly sensitive to assumptions.

If JANE launches at a $250M FDV, the projected returns may look fantastic.

But what if the market values it at:

• $50M?

• $100M?

• $150M?

The expected return changes dramatically.

At that point, the discussion is no longer about yield.

It's about token valuation.

And that's a very different investment thesis.

This is where I realized 3Jane doesn't fit what I'm currently looking for on Pendle.

When I buy PTs, I am usually targeting:

• Discounted future cash flows

• Mispriced yield opportunities

• Market inefficiencies

For example, with PT-sUSDS or similar strategies, I can model expected returns with reasonable confidence.

Likewise, when I analyzed USDD, the key question wasn't token price appreciation.

The thesis was based on a specific event:

Will the protocol extend its incentive program?

That's something I can estimate and assign probabilities to.

3Jane feels different.

The investment case depends heavily on:

• Future JANE valuation

• Future token supply

• Future market sentiment

Those variables are much harder to quantify.

To be clear, I think 3Jane is one of the more interesting projects I've looked at recently.

The team is strong.

The narrative is compelling.

And if on-chain credit markets become a major category, 3Jane could play an important role.

But for now, I see it as a project worth watching rather than investing in.

The opportunity being presented as "100% APY" is, in reality, largely a valuation bet on JANE.

And that's not the type of edge I'm currently looking for.

The most important lesson from researching 3Jane wasn't about credit markets.

It was about understanding where yield actually comes from.

A triple-digit APY sounds exciting.

But before chasing the number, it's worth asking a simple question:

How much of that yield comes from actual cash flow, and how much comes from assumptions?

In the case of 3Jane, the difference matters.

A lot.